AB Klaipėdos nafta preliminary revenue for the January 2021
Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.
The preliminary sales revenue of the Company’s oil terminals for the January 2021 comprises EUR 2.4 million and is higher by EUR 0.4 million or by 20.0 % compared to January of 2020.
The preliminary sales revenue of the Company’s Klaipėda LNG terminal for January 2021 comprises EUR 3.5 million (during the same month of 2020 – EUR 4.3 million). Klaipėda LNG terminal revenue from regulated activities consists of the regasification tariff fixed part (for booked annual capacities), variable part for amount of re-gasified LNG and reloading revenue. The level of Klaipėda LNG terminal revenue (for booked annual capacities) does not depend on regasification volume. Revenue is confirmed by the National Energy Regulatory Council (NERC) based on the approved methodology of State regulated prices in the natural gas sector and is calculated for the whole upcoming year. Klaipėda LNG terminal revenue is lower due to the exceeded return in 2014-2019.
The preliminary sales revenue of the Company’s Commercial LNG activity for the January 2021 comprised EUR 0.2 million and is lower by EUR 0.1 million or by 33.3 % compared to January of 2020. The preliminary sales revenue is higher due to the decrease in consultations of Business development projects compared to the same period of 2020.
Total preliminary sales revenue of the Company for the January 2021 amount to EUR 6.1 million and is lower by 7.6 % compared to the same period of 2020 – EUR 6.6 million.
Preliminary revenue of the Company, EUR million:
January | |||
2021 | 2020 | Change | |
Oil terminals activity | 2.4 | 2.0 | 20.0% |
LNG terminal activity | 3.5 | 4.3 | -18.6% |
Commercial LNG activity | 0.2 | 0.3 | -33.3% |
Total | 6.1 | 6.6 | -7.6% |
Jonas Lenkšas, Chief Financial Officer, +370 694 80594.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Transactions in connection with share buy-back program
- ImmunOs Therapeutics AG Receives Public Funding from Eurostars and Innosuisse for a Novel Therapeutic Antibody to Treat Inflammatory Rheumatic Diseases
- Global Graphics PLC: Notification of transactions in shares by persons discharging managerial responsibility
Create E-mail Alert Related Categories
Globe Newswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!